Last reviewed · How we verify
NCT01808703
Clinical Trial of PeriZone PerioPatch in Subjects With Chronic Periodontitis
NA trial testing PeriZone PerioPatch in Chronic Periodontitis in 80 participants. Status unknown.
1 September 2013
Quick facts
| Lead sponsor | MIS Implant Technologies, Ltd |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 March 2013 |
| Primary completion | 1 September 2013 |
| Estimated completion | 1 September 2013 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- PeriZone PerioPatch
- Scaling and root planing alone
Conditions studied
- Chronic Periodontitis — all drugs for Chronic Periodontitis →
Sponsor
MIS Implant Technologies, Ltd
Who can join
18 and older, any sex, with Chronic Periodontitis. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change in pocket depth (PD)from Baseline
Time frame: At 4, 8 and 12 weeks
PD will be measured from the free gingival margin to the base of the pocket and will be recorded in whole millimeters (mm). If a PD reading falls between two millimeter readings, the rule shall be to round down and the lower of the two readings will be recorded. All sites with PD of 5 mm or more will have two PD readings recorded (multiple-pass probing measurements) per examination time point. The
Sponsor's own description
The purpose of this study is to determine if a topical, adhesive patch (PeriZone PerioPatch) applied to the gums after a deep tooth cleaning (scaling and root planing) reduces the signs of advanced gum disease (chronic periodontitis) more than the deep tooth cleaning alone. Eighty patients with advanced gum disease will be recruited and treated within this clinical trial. Patients will be evaluated for changes in gum measurements over a 12-week period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01808703
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Periodontitis
Currently open trials in the same condition.
- NCT06893107 — Study on Treatment Results and Bone Changes After Replanting Severely Affected Teeth - A Before-and-After Study. · NA · recruiting
- NCT05275192 — Utilization of a Videoscope in Periodontal Regeneration · NA · recruiting
- NCT03741374 — Minimally-invasive Non-surgical Therapy of Intrabony Defects · NA · active not recruiting
- NCT03553095 — Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis · NA · active not recruiting
Other MIS Implant Technologies, Ltd trials
Trials by the same sponsor.
- NCT05979246 — Effect of the Superhydrophilic Surface of Lance CLEAR Implants on the Marginal Bone Loss and Survival in Diabetic and No · NA · unknown
- NCT05552768 — Supracrestal Tissue Attachment Dimensions & Peri-implant Health · NA · unknown
- NCT05975814 — The Effect of Concave Healing Abutment on Soft Tissue Healing · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01808703 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MIS Implant Technologies, Ltd
- Last refreshed: 7 March 2013
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01808703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing